The tumorigenesis and development of ICC are accompanied by abnormal changes in multiple cell signaling pathways, including the EGFR, c-MET, WNT, and AKT/PI3K signaling pathways [33]. The gene discussed is EGFR; the disease is intrahepatic cholangiocarcinoma.